Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gazyva
Pharma
Roche's Gazyva secures FDA nod in 2nd autoimmune indication
Gazyva won FDA approval to reduce relapse risk in patients 2 and older with frequently relapsing or steroid-dependent childhood-onset INS.
Donavyn Coffey
Sep 28, 2026 2:29pm
Roche defends 6B franc Vabysmo peak target despite another miss
Jul 23, 2026 11:32am
UPDATED: Roche Q1 earnings see hits and misses across key products
Apr 24, 2026 1:55pm
Genentech walks the walk in lupus as sponsor of annual event
Mar 26, 2026 11:20am
Roche heads to regulators with new autoimmune win for Gazyva
Feb 17, 2026 10:15am
Roche's Gazyva tees up another lupus expansion with phase 3 win
Nov 3, 2025 11:41am
